These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 1937576)

  • 21. The NK1.1 antigen in NK-mediated F1 antiparent killing in vitro.
    Kung SK; Miller RG
    J Immunol; 1995 Feb; 154(4):1624-33. PubMed ID: 7836747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphokine-activated killer (LAK) cell purging of leukemic bone marrow: range of activity against different hematopoietic neoplasms.
    Long GS; Cramer DV; Harnaha JB; Hiserodt JC
    Bone Marrow Transplant; 1990 Sep; 6(3):169-77. PubMed ID: 2252956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of a syngeneic graft-versus-leukemia effect following bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S; Hows JM; Goldman JM
    Leukemia; 1990 Apr; 4(4):287-91. PubMed ID: 2366584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution.
    Maghazachi AA; Goldfarb RH; Herberman RB
    J Immunol; 1988 Dec; 141(11):4039-46. PubMed ID: 2846699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of natural killer cell production in bone marrow of mice: no evidence for negative feedback control.
    Bilge A; Pollack SB
    Nat Immun; 1992; 11(3):156-66. PubMed ID: 1392403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mouse bone marrow granulocyte-macrophage colony formation by factors derived from natural killer cells: an in vitro model for hybrid resistance.
    Lukomska B; Hansson M; Kiessling R
    J Biol Regul Homeost Agents; 1989; 3(2):55-60. PubMed ID: 2510465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT.
    Keever CA; Klein J; Leong N; Copelan EA; Avalos BR; Kapoor N; Cunningham I; Tutschka PJ
    Bone Marrow Transplant; 1993 Sep; 12(3):289-95. PubMed ID: 8241989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of human natural killer and lymphokine-activated killer cell cytotoxicity against Toxoplasma gondii trophozoites and brain cysts.
    Dannemann BR; Morris VA; Araujo FG; Remington JS
    J Immunol; 1989 Oct; 143(8):2684-91. PubMed ID: 2477453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
    Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
    Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells.
    Baccarini M; Bistoni F; Lohmann-Matthes ML
    J Immunol; 1985 Apr; 134(4):2658-65. PubMed ID: 3882833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The "natural resistance" to bone marrow allografts in normal and athymic nude rats. Rapid cytotoxic reactions both in vivo and in vitro.
    Rolstad B; Benestad HB
    Eur J Immunol; 1984 Sep; 14(9):793-9. PubMed ID: 6383840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-adaptive cellular immune responses as studied in euthymic and athymic nude rats. Spontaneous rejection of allogeneic lymphoid cell grafts by natural killer (NK) cells.
    Rolstad B; Fossum S
    Anat Embryol (Berl); 1990; 181(3):215-26. PubMed ID: 2186665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
    Azuma E; Kaplan J
    J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
    Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
    Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of murine lymphokine-activated killer cells by recombinant IL-7.
    Lynch DH; Miller RE
    J Immunol; 1990 Sep; 145(6):1983-90. PubMed ID: 1975262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F; Basse PH; Hokland M
    Nat Immun; 1996-1997; 15(2-3):134-46. PubMed ID: 9162263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.